-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Gyre Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2010 to Q2 2024.
- Gyre Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 104M shares, a 32.2% increase year-over-year.
- Gyre Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 65.8M shares, a 13% decline from 2022.
- Gyre Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 75.7M shares, a 147% increase from 2021.
- Gyre Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 30.6M shares.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)